Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Nov 8, 2017, during market hours
10-Q filed Nov 8, 2017, 39 days after period end · 0001171843-17-006717
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Revenue | $2.50K | $2.50K | $2.50K | $5.00K |
| Net Income | -$133.78K | -$5.22M | -$5.64M | -$4.46M |
| EPS Diluted | -$0.18 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$0.59 |
| -$0.06 |
| -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
